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The effects of the type of anesthesia on outcomes
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Eric Adams, MD, Shukri Khuri, MD, and William G. Henderson, PhD, Washington, DC
Objective: Three main types of anesthesia are used for infrainguinal bypass: general endotracheal anesthesia (GETA),
spinal anesthesia (SA), and epidural anesthesia (EA). We analyzed a large clinical database to determine whether the
type of anesthesia had any effect on clinical outcomes in lower extremity bypass.
Methods: This study is an analysis of a prospectively collected database by the National Surgical Quality Improvement
Program (NSQIP) of the Veterans Affairs Medical Centers. All patients from 1995 to 2003 in the NSQIP database
who underwent infrainguinal arterial bypass were identified via Current Procedural Terminology codes. The 30-day
morbidity and mortality outcomes for various types of anesthesia were compared by using univariate analysis and
multivariate logistic regression to control for confounders.
Results: The NSQIP database identified 14,788 patients (GETA, 9757 patients; SA, 2848 patients; EA, 2183
patients) who underwent a lower extremity infrainguinal arterial bypass during the study period. Almost all patients
(99%) were men, and the mean age was 65.8 years. The type of anesthesia significantly affected graft failure at 30
days. Compared with SA, the odds of graft failure were higher for GETA (odds ratio, 1.43; 95% confidence interval
[CI], 1.16-1.77; P  .001). There was no statistically significant difference in 30-day graft failure between EA and
SA. Regarding cardiac events, defined as postoperative myocardial infarction or cardiac arrest, patients with normal
functional status (activities of daily living independence) and no history of congestive heart failure or stroke did
worse with GETA than with SA (odds ratio, 1.8; 95% CI, 1.32-2.48; P < .0001). There was no statistically
significant difference between EA and SA in the incidence of cardiac events. GETA, when compared with SA and EA,
was associated with more cases of postoperative pneumonia (odds ratio: 2.2 [95% CI, 1.1-4.4; P  .034]. There was
no significant difference between EA and SA with regard to postoperative pneumonia. Compared with SA, GETA
was associated with an increased odds of returning to the operating room (odds ratio, 1.40; 95% CI, 1.20-1.64; P
< .001), as was EA (odds ratio, 1.17; 95% CI, 1.05-1.31; P  .005). GETA was associated with a longer surgical
length of stay on univariate analysis, but not after controlling for confounders. There was no significant difference
in 30-day mortality among the three groups with univariate or multivariate analyses.
Conclusions: Although GETA is the most common type of anesthesia used in infrainguinal bypasses, our results
suggest that it is not the best strategy, because it is associated with significantly worse morbidity than regional
techniques. ( J Vasc Surg 2006;44:964-70.)The number of individuals affected by peripheral
arterial disease of the lower extremity is increasing rap-
idly as the population in the United States ages.1 Many
of these individuals meet criteria for lower extremity
revascularization, and most are high-risk surgical pa-
tients. Many factors contribute to the morbidity and
mortality of these patients, such as the high incidence of
coronary artery disease. A total of 5% to 15% of patients
undergoing peripheral vascular surgery have periopera-
tive myocardial infarction.2 The results of prior studies
that attempted to investigate the effect of the type of
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964anesthesia on outcomes of infrainguinal bypasses have
varied.3,4
General endotracheal anesthesia (GETA), epidural
anesthesia (EA), and spinal anesthesia (SA) are the three
methods commonly used during lower extremity arterial
bypass surgery. All of these types of anesthesia have been
proven safe in vascular surgery procedures.5 However,
the literature has not been very clear on the issue of
which type of anesthesia a patient receives for infraingui-
nal bypass is the safest in terms of postoperative compli-
cations, including early graft failure. Therefore, the type
of anesthesia used is usually at the discretion of the
anesthesiologist and the surgeon, and it is usually based
on their experience and comfort in the administration of
one type of anesthesia over another.
To examine and compare the safety of the three common
types of anesthesia used, we queried the database of the
Veterans Affairs (VA)National SurgicalQuality Improvement
Program (NSQIP). This database is risk-adjusted, validated,
and peer-controlled. The data are collected in each medical
center by using a trained nurse reviewer.
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Database. The specifics of the VA NSQIP database
have been described in detail in prior studies.6 In brief, 123
VA medical centers in the United States participate in the
NSQIP study by prospectively collecting data on surgical
patients and following up these patients for 30 days for
specific outcomes. All variables in the NSQIP are collected
by dedicated staff in a prospective manner, and patients are
followed up for 30 days after surgery, thus allowing for
effective collection of data on surgical patients in the VA
system undergoing surgery under GETA, EA, and SA.
Sample selection. We queried the database, using
Current Procedural Terminology codes, for all patients
who underwent infrainguinal lower extremity arterial by-
pass procedures from January 1, 1995, to December 31,
2003. The specific infrainguinal bypass codes pulled from
the NSQIP database are listed in Table I. We included all
patients with one of these Current Procedural Terminology
codes and who underwent GETA, EA, or SA.
Outcome variables. The following 30-day postopera-
tive outcomes were analyzed: graft failure (defined as an
occlusion of the new graft necessitating a return to the oper-
ating room [OR] or balloon angioplasty); cardiac event (de-
fined as any postoperative cardiac arrest or myocardial infarc-
tion); postoperative pneumonia (defined by Centers for
Disease Control criteria); related return to theOR (defined as
any return to the OR related to the index procedure); and
postoperative length of stay (LOS). Death was identified via
the Beneficiary Identification and Records Locator System
subsystem (BIRLS).
Baseline patient demographic characteristics and
comorbid conditions. Patient baseline characteristics in-
cluded age, sex, and race (black vs white). Clinical charac-
teristics included in the database were history of stroke,
congestive heart failure (CHF), chronic obstructive pulmo-
nary disease, diabetes (none or diet controlled vs oral
hypoglycemics vs insulin requiring), need for any assistance
with activities of daily living (ADL), and American Society
of Anesthesiologists classification. We also defined current
smoking as smoking cigarettes within 1 year of the opera-
tion and current alcohol use as at least 28 alcoholic drinks in
Table I. Current Procedural Terminology codes for
infrainguinal bypass
Code Procedure
35556 Fem-pop with vein
35566 Fem-AT/PT/Per with vein
35571 Pop-AT/PT/Per with vein
35583 Fem-Pop in situ
35585 Fem-AT/PT/Per in situ
35587 Pop-AT/PT/Per in situ
35656 Fem-Pop with prosthetic
35666 Fem-AT/PT/Per with prosthetic
35671 Pop-AT/PT/Per with prosthetic
Fem, Femoral; Pop, Popliteal; AT, anterior tibial; PT, posterior tibial; Per,
peroneal.the 2 weeks before the operation. Finally, the databaseincluded several preoperative laboratory variables on most
patients, including serum albumin, hematocrit, white blood
cell count, platelet count, prothrombin time, partial throm-
boplastin time, creatinine, and blood urea nitrogen.
Statistical analysis. All of the baseline characteristics
for each individual outcome were screened for inclusion in
the multivariate model by using 2, analysis of variance, or
the Student t test, as appropriate. Because nearly all vari-
ables were associated (P  .25) with either the choice of
anesthesia or the outcome of interest, we entered all vari-
ables into the initial model and then removed variables that
were neither significant nor confounders. We used hierar-
chical logistic regression for multivariate modeling, cluster-
ing by the region of the country.
We also included the institution’s preference for anesthe-
sia into eachmodel. We attempted to use linear regression for
postsurgical LOS, but the heteroscedasticity assumption was
grossly violated, so we reclassified postsurgical LOS into a
binary variable: longest quartile vs all others. Because anes-
thesia choice was the primary exposure of interest, we
checked for interaction between anesthesia type and each
variable that was included in the final model. Final models
were checked for overall goodness of fit by using the
Hosmer-Lemeshow method. All P values were two tailed
with a significance level set at .05. Analyses were conducted
with Stata 8.0 (Stata Corporation, College Station, Tex).
RESULTS
Using the Current Procedural Terminology codes in-
cluded in Table I, we identified 14,788 patients who had
lower extremity infrainguinal surgical revascularizations dur-
ing the study period. Baseline demographic characteristics,
clinical comorbidities, and laboratory data are summarized in
Table II. Because of the large size of the database, the
differences in numerous characteristics are statistically sig-
nificant, although they may not be clinically pertinent
because the actual differences are rather small. For example,
although SA patients had (significantly) the highest albu-
min level, the difference in albumin levels between GETA
and SA patients was 0.08 mg/dL, a difference that is not
clinically pertinent. The number of specific procedures and
the type of anesthesia administered are listed in Table III.
The most common procedures were infrainguinal bypasses
performed with autogenous vein, and femoral-popliteal
bypasses were the most common bypasses. Although most
patients (n 9757; 66%) had GETA, followed by SA (n
2848; 19%) and EA (n  2183; 15%), the proportion of
procedures in each anesthetic group was similar; therefore,
the difference among the 3 groups in morbidity is not due
to the types of procedures performed in each group.
Graft failure. There were a total of 723 (4.9%) graft
failures in this cohort. The type of anesthesia significantly
affected graft failure at 30 days, even after controlling for
confounders in a multivariate model. Compared with SA,
the odds of graft failure were 43% higher for GETA (odds
ratio, 1.43; 95% confidence interval [CI], 1.16-1.77; P 
.001) and trended toward being worse with EA, but this
did not reach statistical significance (Table IV).
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that in patients without a history of CHF or stroke and who
have normal functional status (ADL independence), GETA
was associated with significantly more cardiac events than
SA (odds ratio, 1.8; 95% CI, 1.3-2.5; P .001). There was
no significant difference between EA and SA (P  .2) in
this group. The other variables that were included in the
multivariate model were CHF, stroke, American Society
of Anesthesiologists class IV, nonblack race, age, diabe-
tes, creatinine, white blood cell count, and need for ADL
assistance (Table IV).
Postoperative pneumonia. Those who received GETA
were more likely to be diagnosed with pneumonia within
Table II. Demographic data
Variable G
No. patients 9
Age (y)* 65.5
Male sex (%) 9
Black (%) 1
CHF (%)
COPD (%) 1
Diet-controlled or no diabetes (%) 5
Diabetes with oral hypoglycemic agent (%) 1
Diabetes with insulin (%) 2
Stroke, resolved deficit (%)
Stroke, with deficit (%) 1
Tobacco use (%) 5
Alcohol use (%) 1
Requires ADL assistance (%) 1
Albumin (mg/dL)* 3.59
Creatinine (mg/dL)* 1.36
Blood urea nitrogen (mg/dL)* 19.2
Hematocrit (%)* 37.8
White blood cell count (1000/mm3)* 8.8
Platelet count (1000/mm3)* 264
GETA, General endotracheal anesthesia; SA, spinal anesthesia; GA, general
disease; ADL, activities of daily living.
All comparisons were made against GETA as the reference.
*Mean (SD).
†P  .001, analysis of variance.
‡P  .01, 2 test.
§P  .001, 2 test.
P  .05, 2 test.
¶P  .05, analysis of variance.
#P  .01, analysis of variance.
Table III. Type of procedure performed
Type of procedure GETA
Fem-pop with vein 2724 (28%)
Fem-AT/PT/Per with vein 2358 (24%)
Pop-AT/PT/Per with vein 584 (6%)
Fem-Pop in situ 498 (5%)
Fem-At/PT/Per in situ 852 (9%)
Pop-AT/PT/Per in situ 131 (1%)
Fem-Pop with prosthetic 2052 (21%)
Fem-AT/PT/Per with prosthetic 488 (5%)
Pop-Tib with prosthetic 70 (1%)
Total 9757 (100%)30 days of the procedure than those who received either SAor EA (2.1% vs 1.0% vs 1.0%, respectively; P  .001). This
was again confirmed on multivariate analysis, on which
GETA had higher odds of developing pneumonia (odds
ratio, 2.2; 95% CI, 1.0-4.6; P  .034) vs SA. EA did not
have statistically higher odds of developing pneumonia vs
SA. Other important variables included a history of stroke,
chronic obstructive pulmonary disease, or insulin-requiring
diabetes mellitus; older age; lower albumin; and a white
blood cell count 13 (1000/mm3) (Table IV).
Related return to the OR. In comparison to SA,
GETA was associated with a 40% increase in the odds of a
return to theOR (odds ratio, 1.40; 95%CI, 1.20-1.64; P
.001), and EA was associated with a 17% increase (odds
SA EA
2848 2183
) 66.2 (9.3)† 67 (9.1)†
99.6‡ 99.0
23.4§ 18.9§
4.7 5.4
17.3 21‡
52.4‡ 53.4
20.4‡ 20.8
27.2§ 25.8‡
6.8 7.9‡
9.6 10.2
50‡ 51.4
9.8‡ 12.1
16.9 18.2
4) 3.67 (0.60)† 3.61 (0.61)
) 1.37 (1.2) 1.37 (1.2)
) 19.5 (11) 19.9 (12)¶
) 38.1 (6.0) 38.5 (6.0)†
) 8.6 (2.8)# 8.7 (3.0)
7) 269 (108) 266 (105)
esia; CHF, congestive heart failure; COPD, chronic obstructive pulmonary
EA SA Total
533 (24%) 753 (26%) 4010 (27%)
360 (16%) 626 (22%) 3344 (23%)
103 (5%) 161 (6%) 848 (6%)
121 (6%) 176 (6%) 795 (5%)
176 (8%) 284 (10%) 1312 (8%)
22 (1%) 39 (1%) 192 (1%)
777 (36%) 676 (24%) 3505 (24%)
72 (3%) 113 (4%) 673 (5%)
19 (1%) 20 (1%) 109 (1%)
183 (100%) 2848 (100%) 14,788 (100%)ETA
757
(9.9
8.9
5.7
4.5
8.0
7.3
9
3.7
6.2
0.1
3.5
2
7.1
(0.6
(1.2
(11
(6.2
(4.0
(10
anesthratio, 1.17; 95% CI, 1.05-1.31; P  .005; Table IV). This
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than EA.
Surgical LOS. The average LOS for patients under-
going SA was 10.2 days; for EA, it was 9.4 days; and for
GETA, it was 11.2 days. After controlling for 15 other
variables, multivariate analysis indicated that there was no
significant difference in the postoperative LOS between SA
andGETA (odds ratio, 1.24; 95%CI, 0.99-1.56; P .065)
or between SA and EA (odds ratio, 1.04; 95% CI, 0.84-
1.28; P  .72).
Death. There were 230 deaths in the group studied.
There was no significant difference in 30-day mortality
rates between the 3 types of anesthesia on univariate anal-
ysis or after controlling for confounders (history of stroke,
CHF, chronic obstructive pulmonary disease, American
Society of Anesthesiologists class, diabetes, ADL assistance,
and type of surgery; GETA vs SA, P  .34; GETA vs EA,
P  .14; SA vs EA, P  .13 on multivariate analysis).
DISCUSSION
In this large patient population undergoing infraingui-
nal lower extremity arterial bypass, GETA was the most
commonly used type of anesthetic technique in general and
in every bypass configuration in particular. However,
GETA was associated with worse results in most of the
outcome variables studied. Our results reveal that com-
pared with GETA, SA was associated with superior 30-day
graft patency, fewer cardiac events in patients without CHF
but with normal functional status, less postoperative pneu-
monia, and decreased odds of returning to the OR. In
contrast, SA was significantly better than EA only in the
incidence of return to the OR.
Previous studies have also noted that regional anesthe-
sia was associated with better graft patency than GETA.7,8
In an attempt to find an explanation for this finding, Perler
et al9 noted that GETA and increased plasminogen activa-
tor inhibitor 1 levels were associated with higher rates of
graft occlusion, and Rosenfeld et al10 found increased
postoperative levels of plasminogen activator inhibitor 1 in
the general anesthetic group, with no significant increase in
plasminogen activator inhibitor 1 levels in the epidural-only
group. Further studies by Parker noted that the better graft
patency associated with regional anesthesia may occur be-
Table IV. Outcome variables and type of anesthesia
Outcome variable
GE
Odds ratio 95
Graft failure 1.43 1.1
Cardiac events 1.8 1.3
Postoperative pneumonia 2.2 1.1
Related return to the operating room 1.40 1.2
GETA, General endotracheal anesthesia; EA, epidural anesthesia; CI, confid
Spinal anesthesia was used as the reference in the multivariate model.cause of the modulation of stress.11 In addition, EA hasbeen shown to improve postoperative lower extremity blood
flow by increasing arterial inflow and venous emptying.12
However, not all investigators have been able to con-
firm the detrimental effect of GETA on graft failure. In a
randomized prospective study that was initially intended to
detect cardiac morbidity, Pierce et al13 noted that the type
of anesthesia given did not significantly affect the 30-day
occlusion rate of vascular grafts. Cook et al14 also found no
difference in lower extremity amputation rates in a prospec-
tive study comparing SA and general anesthesia. However,
both of these studies were single-center studies with a
limited number of patients.
Regarding cardiac complications, in contrast to the
current study, in which GETA was found to be worse in
patients with no history of CHF and with a normal func-
tional status, the literature has not been uniform in this
regard.15-18 Although some studies have shown a decrease
in myocardial events in patients undergoing major vascular
surgery who underwent EA,19 most studies have found no
difference in cardiac events in patients undergoing regional
or general anesthesia.20,21
Although there was a higher incidence of the above-
mentioned complications with GETA, this did not translate
into a statistically longer LOS or an increase in 30-day
mortality. Regarding the LOS, the data analyzed were
collected over a very long time period in which the LOS in
VA hospitals sustained a gradual decline. This may have
affected the results that have been averaged over the entire
time period of the study. The 30-day mortality was not
significantly different among the groups, and this may
reflect the overall low mortality in the cohort. Regarding
EA and SA, there were no statistically significant differences
between these two types of anesthesia except in related
returns to the OR, for which there was a 20% higher chance
of return with EA. The clinical significance of this observa-
tion is not clear, and a definite conclusion regarding the
superiority of SA vs EA cannot be made on the basis of this
one outcome.
This study has the limitations that are inherent with
retrospective reviews of large databases. For example, the
specific agents used for anesthesia and analgesia in these
patients are not available. It is also difficult to ascertain
the specific nuances of each particular case. Redo proce-
EA
P value Odds ratio 95% CI P value
7 .001 1.39 0.97-2.0 .075
8 .0001 1.37 0.80-2.35 .257
0 .034 1.04 0.64-1.72 .085
4 .001 1.17 1.05-1.31 .005
interval.TA
% CI
6-1.7
2-2.4
0-4.4
0-1.6
encedures and those that required spliced vein or arm vein
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ried via Current Procedural Terminology codes, and
there were no separate codes for these procedures;
add-on codes that describe these configurations became
available only in the last 5 years. Additionally, operative time
could not be calculated because this was not included in the
dataset, and indications for the procedures cannot be iden-
tified in this database. Thus, even though the distribution
of infrainguinal bypass procedure types between the anes-
thesia groups was equivalent, we cannot exclude the poten-
tial that GETA was used for infrainguinal bypass proce-
dures that were more complex, and this could have
influenced our results. Regardless, the reporting standards
of NSQIP are strict, and the data are extremely well col-
lected. Furthermore, the significance of our study includes
its size, prospective collection of the data, and data adjust-
ment. In addition, the procedures were performed in many
centers, and this makes the results of this current study
more applicable to the general population than single-
center results.
As with any retrospective review of prospectively col-
lected data, one always believes that a randomized prospec-
tive study is needed to elucidate further a true difference in
outcomes. We used the data for graft failure collected from
our study to estimate the sample size needed for a random-
ized control trial (  .05 and   .20) and noted that
more than 20,000 patients divided equally among the 3
anesthesia groups would be required to show statistical
significance. Even in a multicenter trial, it is rather difficult
to obtain such a large cohort of patients, especially now in
the age of endovascular therapy. This highlights the signif-
icance of the current study.
In conclusion, although GETA continues to be used
more often than any other type of anesthesia for lower extrem-
ity infrainguinal bypasses, our data suggest that GETA is
associated with a significantly worse 30-day outcome when
compared with regional anesthesia. However, this worse
outcome was limited to complications and not mortality.
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Dr Bruce Perler (Baltimore, Md). Working in a teaching
hospital, it pains me to recall the dozens of hours I’ve wasted
pacing the halls waiting for an anesthesia resident to place a spinal
or epidural anesthesia. In fact, for years, I pontificated the adage
that “general anesthesia means never having to say you’re sorry.”
I must say, in all candor, I’m now a born-again believer in
regional anesthesia. And my awakening came as a result of a
randomized prospective trial we did at Hopkins in which we
showed that the rate of perioperative graft thrombosis was signif-
icantly lower among patients who had their surgery under regional
anesthesia.
In the largest series, looking at this issue reported to date, Dr
Singh and his colleagues, looking at nearly 15,000 cases, have
confirmed our results. Specifically, the rate of 30-day graft failure
was 43% higher among patients undergoing general as opposed to
spinal anesthesia.
These results really should not be surprising, since we know
that regional anesthesia has several physiologic effects which might
promote graft flow and enhance very early graft patency. Regional
anesthesia produces a transient sympathetic blockade resulting in
increased venous arterial flow, venous capacitance, and venous
emptying. In addition, regional anesthesia modulates the surgical
stress response, which is typically characterized by a rise in cat-
echolamines, aldosterone, angiotensin, renin, and cortisol levels.
So while the surgeon’s blood pressure and heart rate may increase
while waiting for the anesthetic, the patient clearly benefits from a
reduced level of circulating, vasoconstricting agents further pro-
moting arterial flow. The surgical stress is also characterized by a
transient hypercoagulability state, which is attenuated by regional
anesthesia.
I have three questions for the authors.
While your data clearly demonstrate significant and superior
early patency for spinal as opposed to general anesthesia, you also
found a trend bordering on statistical significance for a higher early
graft thrombosis rate among patients undergoing epidural anes-
thesia. Since the beneficial physiologic effects of epidural and spinal
anesthesia are similar, this observation seems counterintuitive.
How do you explain the seemingly inferior results with epidural
compared to spinal anesthesia?
Second, you observed that among patients with normal func-
tional status and no history of congestive failure, spinal anesthesia
was associated with a significantly reduced incidence of cardiac
complications. I would assume that the cardioprotective effects of
regional anesthesia would be most pronounced and clinically most
beneficial among patients with significant cardiac disease. Why
didn’t you include patients with significant cardiac histories, who
probably reflect a major proportion of our practices, in the analysis?
And finally, in light of the lower incidence of graft, cardiac,
and pulmonary complications associated with regional anesthesia, I
was surprised to see that there was no demonstrated benefit in
terms of length of stay. Why was this reduced incidence of com-
plications not reflected in a significantly reduced length of stay?
I think this is a very important paper. I congratulate Dr Singh
on an excellent presentation and thank the Society for the privilege
of the floor.
Dr Singh. Thank you, Dr Perler. You’re obviously one of the
pioneers in this field looking at the effects of anesthesia on lower
extremity bypass.
Regarding the first question, why do I think epidural anesthe-
sia is associated with worse outcomes than spinal anesthesia? In
your work, you describe the beneficial effects of regional vs general
anesthesia, and I do not think based upon the past literature and
now there should be much difference between spinal and epidural.
In essence, there was only one category that was statistically
significant, and that was takebacks to the operating room, where
epidural anesthesia was worse than spinal anesthesia. The odds
ratio was 1.07.The other area where it approached, but was not statistically
significant, was in graft failure. But to answer your question, it’s
hard to discern, based on our database, why that would be—why
there would be a trend towards better outcomes with spinal
anesthesia. As I showed, sicker patients are undergoing regional
anesthesia, mostly spinal anesthesia, and significantly more patients
are undergoing femoral-to-tibial bypass. Based on our database, I
can’t answer why I think that there’s a trend towards better
outcomes with spinal anesthesia.
Regarding No. 2, the functional status and the effects on
cardiac outcomes, normal functional status and no history of CHF
were associated with better outcomes in multivariate analysis.
Patients with more comorbidities were undergoing regional anes-
thesia and, for most outcomes, did better.
Regarding length of stay, these are VA patients in the VA
system, and generally their length of stay is longer after lower
extremity bypass. It may reflect different cost constraints than
other hospitals have or possibly lack of ancillary rehabilitative
facilities available to hospitals in more rural locations.
Dr Keith D. Calligaro (Philadelphia, Pa). My question for
you is if you analyzed the duration of time of the surgery for the
different groups. And the reason I ask that is, although I agree with
your findings, there are problems with such a large retrospective
study. If a surgeon is doing a fem-tib bypass on a patient who will
need splicing of 2 or 3 segments of vein and maybe arm vein
segments. Those patients are more likely going to undergo general
anesthesia, with a much longer duration of surgery, compared with
a patient who is getting a fem-pop prosthetic graft, which you can
do under spinal. So did you look at the time of surgery?
Dr Singh. There is a time factor that is provided by NSQIP;
however, it was not consistently collected for each patient in our
dataset. Therefore, we did not analyze the time.
I agree, you have to know your limitations with timing.
Obviously, if you are using upper extremity vein, general anesthesia
and a longer duration of anesthesia will be needed. However, in
our series, roughly the same proportions of femoral to tibial artery
bypasses were under spinal (36%) as were done under general
(38%), with better outcomes in the spinal group. This reflects the
surgeon likely understanding the time constraints of spinal.
Dr Ellen Dillavou (Pittsburgh, Pa). My question is very
closely related to Dr Calligaro’s, in that do you think it’s possible
that the differences you saw between spinal and epidural anesthesia
were related to patient selection rather than anesthetic alone? Do
you have continuous spinal? What we have with spinal anesthesia is
probably a 3- to 4-hour window maximum. And so are you then
selecting for better outcome patients with shorter surgeries and
that’s the differences you’re seeing between the groups?
Dr Singh. Our database does discern patients based on the
type of anesthesia. It doesn’t say whether it’s continuous spinal or
not.
DrDillavou.Did you look at the type of procedure in relation
to the anesthetic?
Dr Singh. Looking at the type of anesthetic, 54% of the
patients in the general anesthesia group underwent a femoral-to-
popliteal bypass.
In the spinal anesthetic group, 56% of the patients underwent
a femoral-to-popliteal artery bypass. In the general anesthesia
group, 38% underwent a femoral to tibial artery bypass, and in the
spinal group, 36%. So we had very similar proportions of patients in
each group.
Obviously, like Dr Calligaro said, you have to be selective in
the type of operation. If you’re splicing vein and you’re doing
other things, then spinal anesthetic may not be the best choice of
anesthesia in that situation.
Dr Theodore S. Pabst III (Plattsburgh, NY). I very much
enjoyed your presentation. Two questions: One, the typical
problem that I encounter with my anesthesiologists is that they
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Did you have anything in your database that said anything about
that?
And second, you noticed an increased risk of cardiac compli-
cations, pulmonary complications, and returns to the OR, but that
didn’t translate into a greater 30-day mortality rate. Can you
explain the difference in that?
Dr Singh. Regarding the trends and not having an increase inWe use the beneficiary identification records locater system at the
VA to do that. And you can get very good data collection from
that, and you can take it out to a longer period of time. But we
looked at specific 30-day outcomes. And the immediate death rate
was not significantly different between the three groups.
With regard to spinal complications, we have complications
overall, but it’s not limited to spinal complications. We didn’t look
at specific outcomes in regard to anesthesia as far as spinal misad-the death rate, it’s hard to explain that. We have 30-day outcomes. ventures.
